PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic finds early success with laser that destroys tumors with heat

2010-10-15
(Press-News.org) JACKSONVILLE, Fla. — Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated — meaning no visible tumors remained after the procedure.

They join their colleagues at Mayo Clinic's site in Rochester, Minn., who were the first to use laser ablation on patients with recurrent prostate tumors.

Although the treatment techniques are in the development stage, the physicians say the treatment is potentially beneficial against most tumors in the body — either primary or metastatic — as long as there are only a few in an organ and they are each less than 5 centimeters in size (about 2 inches in diameter). Patients also cannot have a pacemaker or certain metallic implants, since the procedure is done inside an MRI machine.

"Laser ablation offers us a way to precisely target and kill tumors without harming the rest of an organ. We believe there are a lot of potential uses of this technique — which is quite exciting," says Eric Walser, M.D., an interventional radiologist who has pioneered the technique at Mayo Clinic, Florida.

In the United States, laser ablation is primarily used to treat brain, spine and prostate tumors, but is cleared by the U.S. Food and Drug Administration (FDA) for any soft tissue tumor. Only a few centers have adapted the technique to tumors outside of the brain.

Dr. Walser has been using laser ablation since June. He learned the technique in Italy, where its use is more common, and he adapted it for patients at Mayo Clinic, Florida, many of whom are on a liver transplant waiting list. The clinic is a large liver transplant center, and a number of patients with cirrhosis have small tumors in their liver. "We treated the tumors to keep them at bay because we could not use chemotherapy in these patients, who are quite ill and are waiting for a new liver," he says. He also adapted it for use in treating kidney tumors.

The outpatient procedure is performed inside an MRI machine, which can precisely monitor temperature inside tumors. A special nonmetal needle is inserted directly into a tumor, and the laser is turned on to deliver light energy. Physicians can watch the temperature gradient as it rises, and they can see exactly in the organ where the heat is. When the tumor and a bit of tissue that surrounds it (which may harbor cancer cells) is heated to the point of destruction — which can be clearly seen on monitors — the laser is turned off. In larger tumors, several needles are inserted simultaneously.

Patients are given anesthesia because, during the 2.5-minute procedure they should not move, Dr. Walser says. Post-treatment side effects include some local pain and flulike symptoms as the body reacts to, and absorbs, the destroyed tissue, he says. These side effects usually subside in three days to one week.

Dr. Walser adds that laser ablation is a much more precise technology than similar methods that use probes, such as radiofrequency ablation, which also raises a tumor's temperature, and cryotherapy, which freezes tumors.

David Woodrum, M.D., Ph.D., from Mayo Clinic, Rochester, has also reported success using the new technique.

At the March meeting of the Society of Interventional Radiology, Dr. Woodrum, presented results from the first known cases of using MRI-guided laser ablation to treat prostate tumors. He said then that the safe completion of four clinical cases using the technique to treat prostate cancer in patients who had failed surgery "demonstrates this technology's potential."

Dr. Woodrum has now treated seven patients, including a patient with melanoma whose cancer had spread to his liver.

"MRI-guided ablation may prove to be a promising new treatment for prostate cancer recurrences," he says. "It tailors treatment modality (imaging) and duration to lesion size and location and provides a less invasive and minimally traumatic alternative for men."

Mayo is the country's leader in adapting the use of MRI-guided ablation for tumors outside of the brain, say the physicians, who have been collaborating on expanding use of the technology with Visualase Inc., of Houston. The company received FDA clearance in October 2009 for use of laser ablation. Neither Dr. Walser nor Dr. Woodrum has a financial arrangement with the company or a conflict of interest.

### About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers, and 50,100 allied health staff work at Mayo Clinic, which has campuses in Rochester, Minn; Jacksonville, Fla; and Scottsdale/Phoenix, Ariz.; and community-based providers in more than 70 locations in southern Minnesota., western Wisconsin and northeast Iowa. These locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education, visit www.mayo.edu. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories.

END



ELSE PRESS RELEASES FROM THIS DATE:

Perspectives on improving patient care: Genetics, personalized medicine, and behavioral intervention

2010-10-15
Personalized medicine — improving the fit between patient and treatment — has become a major focus of research in fields from cancer treatment to the psychopharmacology of mental disorders. Genetic studies have suggested that an individual's genetic makeup renders him either more or less sensitive to stressful social environments — but can an individual's unique genotype also determine the effectiveness of preventative or therapeutic behavioral interventions? The current issue of Perspectives on Psychological Science, a journal of the Association for Psychological Science, ...

Study: Waist circumference, not BMI, is best predictor of future cardiovascular risk in children

2010-10-15
Athens, Ga. – A new long-term study published by researchers at the University of Georgia, the Menzies Research Institute in Hobart, Australia and the Murdoch Childrens Research Institute in Melbourne, Australia suggests that waist circumference, rather than the commonly used body mass index measure, is the best clinical measure to predict a child's risk for cardiovascular disease and diabetes later in life. The researchers, whose results appear in the early online edition of the International Journal of Obesity, found that children with high waist circumference values ...

UT Dallas researcher helps reveal more complete picture of Martian atmosphere

2010-10-15
Instruments designed by a UT Dallas professor to measure atmospheric components on the surface of Mars have uncovered important clues about the planet's atmosphere and climate history. The findings, published in a recent issue of the journal Science, reveal how carbon dioxide isotopes have reacted to volcanic activity, water and weathering – thus forming a more complete picture of the current Martian atmosphere. The NASA mission in which this work was accomplished was the Phoenix Lander, an unmanned spacecraft deployed to Mars in 2008. UT Dallas Physics Professor ...

Anti-vomiting drug could prevent thousands of hospitalizations, save millions of dollars

2010-10-15
CHAPEL HILL – Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis. Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars ...

UCSB scientists discover inner workings of potent cancer drug

UCSB scientists discover inner workings of potent cancer drug
2010-10-15
(Santa Barbara, Calif.) –– A potent drug derived from an evergreen tree may soon save the lives of some patients with the deadliest form of breast cancer. According to the National Cancer Institute, breast cancer will claim approximately 40,000 lives in the U.S. this year. Scientists at UC Santa Barbara, in cooperation with scientists in the pharmaceutical industry, have discovered the mechanism by which this drug kills cancer cells. The team has isolated the drug's action in the test tube as well as in cancer cells. The results are reported in two studies published ...

Temperature rhythms keep body clocks in sync, UT Southwestern researchers find

2010-10-15
DALLAS – Oct. 14, 2010 – Researchers at UT Southwestern Medical Center have found that fluctuations in internal body temperature regulate the body's circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions. A light-sensitive portion of the brain called the suprachiasmatic nucleus (SCN) remains the body's "master clock" that coordinates the daily cycle, but it does so indirectly, according to a study published by UT Southwestern researchers in the Oct. 15 issue of Science. The SCN responds to light entering the eye, and so is sensitive ...

Researchers report advances vs. preeclampsia, including potential prediction

2010-10-15
PROVIDENCE, R.I. [Brown University] — In as many as 8 percent of pregnancies worldwide, women who seem fine for months develop preeclampsia, a serious complication causing symptoms including high blood pressure, severe swelling, and problems with placental development. The untreatable and unpredictable condition, with no known cause, often requires premature delivery, and can sometimes kill the mother and the fetus. In a new study, researchers led by a team at Brown University and Women & Infants Hospital describe two major advances: a well-defined animal model of preeclampsia ...

Researcher find fats galore in human plasma

Researcher find fats galore in human plasma
2010-10-15
Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood. "Everybody knows about blood lipids like cholesterol and triglycerides," said Edward A. Dennis, PhD, distinguished professor of pharmacology, chemistry and biochemistry at UC San Diego and ...

Need a study break to refresh? Maybe not, say Stanford researchers

2010-10-15
It could happen to students cramming for exams, people working long hours or just about anyone burning the candle at both ends: Something tells you to take a break. Watch some TV. Have a candy bar. Goof off, tune out for a bit and come back to the task at hand when you're feeling better. After all, you're physically exhausted. But a new study from Stanford psychologists suggests the urge to refresh (or just procrastinate) is – well – all in your head. In a paper published this week in Psychological Science, the researchers challenge a long-held theory that willpower ...

'Incoherent excitations' govern key phase of superconductor behavior: UBC research

2010-10-15
New research by University of British Columbia physicists indicates that high-temperature superconductivity in copper oxides is linked to what they term 'incoherent excitations'--a discovery that sheds light on the electronic response of these materials before they become superconducting. The study marks the first time researchers have been able to directly measure when electrons in a super conductor behave as independent well-defined particles, and when they evolve into ill-defined many-body entities. "We've never been able to directly quantify the nature of electron ...

LAST 30 PRESS RELEASES:

Sugar, the hidden thermostat in plants

Personality can explain why some CEOs earn higher salaries

This puzzle game shows kids how they’re smarter than AI

Study suggests remembrances of dead played role in rise of architecture in Andean region

Brain stimulation can boost math learning in people with weaker neural connections

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds

Neurotechnology reverses biological disadvantage in maths learning

UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning

Scientists target ‘molecular machine’ in the war against antimicrobial resistance

Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting

Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating

Thunderstorms are a major driver of tree death in tropical forests

Danforth Plant Science Center adds two new faculty members

Robotic eyes mimic human vision for superfast response to extreme lighting

Racial inequities and access to COVID-19 treatment

Residential segregation and lung cancer risk in African American adults

Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’

Capturability distinction analysis of continuous and pulsed guidance laws

CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day

Exposure to air pollution may cause heart damage

SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight

Prebiotics might be a factor in preventing or treating issues caused by low brain GABA

Youngest in class at higher risk of mental health problems

American Heart Association announces new volunteer leaders for 2025-26

Gut microbiota analysis can help catch gestational diabetes

FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship

Champions for change – Paid time off initiative just made clinical trials participation easier

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

[Press-News.org] Mayo Clinic finds early success with laser that destroys tumors with heat